SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity

Project description

SmartHeart: 3D heart model to aid drug discovery

During the drug discovery process, drugs under development are initially tested on animal models. However, there is an overall consensus to reduce animal experiments as much as possible, replacing them with in vitro models of disease. With this in mind, the EU-funded SmartHeart project is working on an innovative 3D in vitro cardiac assay that employs induced pluripotent stem cell-derived cardiomyocytes grown in a microstructured gel. The SmartHeart assay will allow the qualitative and quantitative measurement of several cardiac parameters as well as the sub-cellular structure observation via high resolution imaging techniques. The technology will be available in multi-well format suitable for high throughput screening processes.

Fields of science

• medical and health sciences › medical biotechnology › cells technologies › stem cells

Programme(s)

• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2019 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2019
See other projects for this call

Funding Scheme

MSCA-IF-EF-SE - Society and Enterprise panel

Coordinator

4DCELL

Address

14 Rue De La Beaune Bat C Etage 2
93100 Montreuil
France

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 196 707,84